Monoclonal anti-MUC1 antibody with novel octahydropyrazino[2,1-a:5,4-a′]diisoquinoline derivative as a potential multi-targeted strategy in MCF-7 breast cancer cells

The aim of the present study was to examine the multi-targeted potential of a monoclonal antibody against mucin-1 (MUC1) and novel octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivative (OM-86II) in estrogen receptor-positive MCF-7 human breast cancer cells. The cell viability was measured by an MT...

Descripción completa

Detalles Bibliográficos
Autores principales: Gornowicz, Agnieszka, Szymanowski, Wojciech, Bielawska, Anna, Szymanowska, Anna, Czarnomysy, Robert, Kałuża, Zbigniew, Bielawski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718100/
https://www.ncbi.nlm.nih.gov/pubmed/31524251
http://dx.doi.org/10.3892/or.2019.7256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718100/
https://www.ncbi.nlm.nih.gov/pubmed/31524251
http://dx.doi.org/10.3892/or.2019.7256

Ejemplares similares